1. Cholecystectomy for mild gallstone pancreatitis
2. Exclusion criteria and the effect on adenoma detection rate
3. Risk factors for prediction of cancer after initial colonoscopy
4. Clopidogrel with proton pump inhibitors
5. Weight loss and nonalcoholic steatohepatitis
6. Long-term safety of PPI therapy
7. Grazoprevir-Elbasvir combination therapy for HCV
8. Fecal microbiota transplantation for Clostridium difficile
9. Barrett’s esophagus diagnosis and management
10. Hepatitis B reactivation during immunosuppressive drug therapy
More articles on gastroenterology:
EndoChoice receives “strong buy” rating from analysts: 4 points
FDA warns against use of AbbVie’s hepatitis C treatments: 5 key notes
5 most-read GI/endoscopy stories: Week of Dec. 21 – Dec. 25
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
